Bausch Health Companies (BHC) Interest Coverage Ratio (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Interest Coverage Ratio came in at 1.87 in Q2 2026, up 95.71% year-over-year from 0.95 in Q2 2025, and up 179.07% quarter-over-quarter from 2.36 in Q1 2026.
Analysis
Bausch Health Companies (BHC) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Interest Coverage Ratio across 18 years of filings, most recently posting 1.87 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio rose 95.71% year-over-year to 1.87; the TTM figure through Jun 2026 stood at 0.55 (down 49.12% YoY), while the FY2025 annual figure was 1.13, up 1.48% from the prior year.
- Interest Coverage Ratio came in at 1.87 for Q2 2026 at Bausch Health Companies, up from 2.36 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.87 in Q2 2026 to a low of 2.36 in Q1 2026.
- Average Interest Coverage Ratio over 5 years is 0.69, with a median of 0.88 recorded in 2024.
- Year-over-year, Interest Coverage Ratio jumped 2125.47% in 2024 and plunged 382.55% in 2026.
- Over 5 years, Interest Coverage Ratio stood at 0.77 in 2022, then surged by 229.73% to 1.0 in 2023, then soared by 66.04% to 1.66 in 2024, then fell by 27.89% to 1.19 in 2025, then surged by 56.51% to 1.87 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 1.87 in Q2 2026, 2.36 in Q1 2026, and 1.19 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 3.02 |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 1.87 |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -1.79 |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 579.00 |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.87 |
| Mar 31, 2026 | -2.36 |
| Dec 31, 2025 | 1.19 |
| Sep 30, 2025 | 1.50 |
| Jun 30, 2025 | 0.95 |
| Mar 31, 2025 | 0.84 |
| Dec 31, 2024 | 1.66 |
| Sep 30, 2024 | 0.92 |
| Jun 30, 2024 | 1.11 |
| Mar 31, 2024 | 0.79 |
| Dec 31, 2023 | 1.00 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 1.29 |
| Mar 31, 2023 | 0.57 |
| Dec 31, 2022 | -0.77 |
| Sep 30, 2022 | 0.63 |
| Jun 30, 2022 | 0.39 |
| Mar 31, 2022 | 0.79 |
| Dec 31, 2021 | 1.07 |
| Sep 30, 2021 | 1.64 |